SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 195.35-0.8%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (18432)4/1/1998 9:13:00 PM
From: Henry Niman  Read Replies (1) of 32384
 
Here's the table from the diabetes review in thestreet.com:
There are 160 compounds in various stages of development (I think they are listed as most advanced or promising :-))

COMPANY NAMES
COMPOUND(S)
ACTION
DEVELOPMENTAL
STAGE
Ligand
(LGND:Nasdaq)
& Lilly
(LLY:NYSE)
Targretin,
LGD 1268,
LGD 1324
Insulin receptor
agonist
Phase III
Alteon
(ALTN:Nasdaq)
& Genentech
(GNE:NYSE)
Pimagedine
Advanced
glycosylation
end product
inhibitor
Phase III
Amylin
(AMLN:Nasdaq)
& Johnson &
Johnson
(JNJ:NYSE)
Pramlintide
"Hormone"
analogue
Phase III
SmithKline
Beecham
(SBH:NYSE
ADR)
Rosiglitazone
Insulin
sensitizer
Phase III
Pfizer
(PFE:NYSE)
Zopolrestat
Aldose
reductase
inhibitor
Phase III
Amgen
(AMGN:Nasdaq)
Leptin
Regulator of
ob(ese) gene
Phase II
AutoImmune
(AIMM:Nasdaq)
AI 401
Oral tolerance
Phase II
Emisphere
(EMIS:Nasdaq)
& Lilly
Insulin
Oral insulin
Phase I
Lilly
LY 333531
Protein kinase
C inhibitor
Phase II
Genzyme
(GENZ:Nasdaq)
GAD
Recombinant
glutamic acid
decarboxylase
Preclinical
Transkaryotic
Therapies
(TKTX:Nasdaq)
Insulin gene
Gene therapy
Preclinical
Pfizer
(PFE:NYSE)
Englitazone
Insulin
sensitizer
Preclinical
Lilly & McGill
and Virginia
Universities
INGAP
Regenerates
islet cells
Preclinical
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News